**Core Concept**
The question tests knowledge of antiretroviral drugs that inhibit the entry of the human immunodeficiency virus (HIV) into host cells. This involves understanding the HIV life cycle and the role of **entry inhibitors**.

**Why the Correct Answer is Right**
The correct answer involves drugs that block the entry of HIV into host cells by targeting the **CD4 receptor** or the **CCR5 co-receptor** on the surface of T-cells. These drugs prevent the **gp120** protein of HIV from binding to the host cell receptor, thereby inhibiting viral entry.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because it refers to a different class of antiretroviral drugs.
**Option B:** Incorrect as it is not directly related to inhibiting HIV entry into host cells.
**Option C:** Incorrect because it targets a different stage of the HIV life cycle.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **entry inhibitors** are a class of antiretroviral drugs used in combination therapy to treat HIV infection, highlighting the importance of understanding the HIV life cycle in treating the disease.

**Correct Answer:** D. Entry Inhibitors, such as Enfuvirtide.